UBS Group’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $942K | Sell |
428,216
-81,994
| -16% | -$180K | ﹤0.01% | 4398 |
|
|
2025
Q1 | $1.1M | Buy |
510,210
+107,813
| +27% | +$233K | ﹤0.01% | 4120 |
|
|
2024
Q4 | $1.7M | Buy |
402,397
+367,389
| +1,049% | +$1.55M | ﹤0.01% | 3845 |
|
|
2024
Q3 | $400K | Buy |
35,008
+32,318
| +1,201% | +$370K | ﹤0.01% | 4239 |
|
|
2024
Q2 | $28.8K | Buy |
2,690
+1,823
| +210% | +$19.5K | ﹤0.01% | 5936 |
|
|
2024
Q1 | $13.3K | Buy |
+867
| New | +$13.3K | ﹤0.01% | 5937 |
|